Key Takeaways
- Aurobindo’s CuraTeQ has received approval from the UK’s Medicines and Healthcare products Regulatory Agency for its Zefylti (filgrastim) biosimilar.
Aurobindo has notched up yet another European biosimilar approval in a relatively short period, this time receiving a nod from...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?